Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by health care providers who care for patients who either have or are at risk of these infections. Since 2004, several new antifungal agents have become available, and several new studies have been published relating to the treatment of candidemia, other forms of invasive candidiasis, and mucosal disease, including oropharyngeal and esophageal candidiasis. There are also recent prospective…

• A
  Amgen
• P
  Pfizer
• A
  AstraZeneca
• GS
  Gilead Sciences
• ID
  Infectious Diseases Society of America
• AP
  Astellas Pharma
• BP
  Basilea Pharmaceutica
• NI
  National Institutes of Health
• CF
  Centers for Disease Control and Prevention
• PP
  Pfizer Pharmaceuticals
• NI
  National Institute of Child Health and Human Development